Skip to content
Disclosery

M28 Capital Management LP

Follow

13F filer, CIK 1807489, STAMFORD, CT

M28 Capital Management LP reported $47,155,240 across 9 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000902664-26-003441

Period
2026-06-30
Reported value
$47.2M
Holdings
9
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0000902664-26-003441, largest first. % of portfolio is the value over $47,155,240, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 6,164,548 shares; 2024Q4: 5,664,548 shares; 2025Q1: 5,664,548 shares; 2025Q2: 5,664,548 shares; 2025Q3: 5,664,548 shares; 2025Q4: 5,664,548 shares; 2026Q1: 4,588,284 shares; 2026Q2: 4,588,284 shares 4,588,284$26.7M56.53%0Timeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 9,248,250 shares; 2024Q4: 9,248,250 shares; 2025Q1: 9,248,250 shares; 2025Q2: 9,248,250 shares; 2025Q3: 9,248,250 shares; 2025Q4: 9,248,250 shares; 2026Q1: 9,248,250 shares; 2026Q2: 9,248,250 shares 9,248,250$8.07M17.11%0Timeline
TGTXTG THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 161,600 shares; 2024Q4: 161,600 shares; 2025Q1: 161,600 shares; 2025Q2: 161,600 shares; 2025Q3: 161,600 shares; 2025Q4: 161,600 shares; 2026Q1: 88,354 shares; 2026Q2: 88,354 shares 88,354$4.85M10.29%0Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 67,400 shares; 2024Q4: 67,400 shares; 2025Q1: 67,400 shares; 2025Q2: 67,400 shares; 2025Q3: 67,400 shares; 2025Q4: 67,400 shares; 2026Q1: 36,851 shares; 2026Q2: 36,851 shares 36,851$3M6.37%0Timeline
GUTSFRACTYL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,856,117 shares; 2024Q4: 1,856,117 shares; 2025Q1: 1,856,117 shares; 2025Q2: 1,856,117 shares; 2025Q3: 1,856,117 shares; 2025Q4: 1,856,117 shares; 2026Q1: 1,856,117 shares; 2026Q2: 1,856,117 shares 1,856,117$1.47M3.13%0Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,019,498 shares; 2024Q4: 1,019,498 shares; 2025Q1: 1,019,498 shares; 2025Q2: 1,019,498 shares; 2025Q3: 1,019,498 shares; 2025Q4: 1,019,498 shares; 2026Q1: 599,793 shares; 2026Q2: 599,793 shares 599,793$1.12M2.37%0Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 185,100 shares; 2024Q4: 185,100 shares; 2025Q1: 185,100 shares; 2025Q2: 185,100 shares; 2025Q3: 185,100 shares; 2025Q4: 185,100 shares; 2026Q1: 101,203 shares; 2026Q2: 101,203 shares 101,203$1.11M2.36%0Timeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 385,680 shares; 2024Q4: 385,680 shares; 2025Q1: 385,680 shares; 2025Q2: 385,680 shares; 2025Q3: 385,680 shares; 2025Q4: 385,680 shares; 2026Q1: 210,871 shares; 2026Q2: 210,871 shares 210,871$721K1.53%0Timeline
CRISCURIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 421,951 shares; 2024Q4: 521,059 shares; 2025Q1: 521,059 shares; 2025Q2: 521,059 shares; 2025Q3: 521,059 shares; 2025Q4: 521,059 shares; 2026Q1: 284,889 shares; 2026Q2: 284,889 shares 284,889$149K0.32%0Timeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000902664-26-003441 base2026-08-13acceptance time not in the bulk data set